deferoxamine has been researched along with quinoxalines in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Yoseph, O; Boxer, PA; Ross, BD | 1 |
| Sah, R; Schwartz-Bloom, RD | 1 |
| Branco, LG; Steiner, AA | 1 |
| Cohen, MV; Cui, L; Downey, JM; Kelm, M; Ludolph, B; Philipp, S; Schulz, R | 1 |
| Gebhardt, P; Grosse-Gehling, P; Irmler, I; Kamradt, T; Khalid, M; Opfermann, T; Preusche, S; Saluz, HP; Steinbach, J; Walther, M; Würbach, L | 1 |
| Kasukabe, T; Kumakura, S; Yamaguchi, Y | 1 |
| Baatarjav, C; Higashi, T; Kamata, R; Karasawa, T; Komada, T; Ohno, N; Sampilvanjil, A; Takahashi, M; Watanabe, S; Yamada, N | 1 |
| Cho, SS; Ki, SH; Kim, KM | 1 |
| An, H; Bao, Y; Huang, D; Shen, N; Wang, K; Yang, J; Yu, F; Zeng, X; Zheng, L; Zhou, W | 1 |
1 review(s) available for deferoxamine and quinoxalines
| Article | Year |
|---|---|
Emerging roles of ferroptosis in liver pathophysiology.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Carcinoma, Hepatocellular; Cycloheximide; Cyclohexylamines; Deferoxamine; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Ferroptosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Spiro Compounds | 2020 |
8 other study(ies) available for deferoxamine and quinoxalines
| Article | Year |
|---|---|
Noninvasive assessment of the relative roles of cerebral antioxidant enzymes by quantitation of pentose phosphate pathway activity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbon Isotopes; Caudate Nucleus; Cells, Cultured; Cerebral Cortex; Deferoxamine; Deuterium; Dizocilpine Maleate; Fetus; Gas Chromatography-Mass Spectrometry; Glucose; Hydrogen Peroxide; Iron; Kainic Acid; Kinetics; N-Methylaspartate; Neuroglia; Neurons; Pentose Phosphate Pathway; Putamen; Quinoxalines; Rats | 1996 |
Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antioxidants; Cell Membrane Permeability; Chlorides; Chromans; Deferoxamine; Extracellular Space; Fluorescent Dyes; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Hydrogen Peroxide; In Vitro Techniques; Kinetics; Microscopy, Confocal; Muscimol; Nipecotic Acids; Oxidative Stress; Pyramidal Cells; Quinolinium Compounds; Quinoxalines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tiagabine | 1999 |
Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway.
Topics: Animals; Biliverdine; Body Temperature Regulation; Brain; Carbon Dioxide; Cerebral Ventricles; Deferoxamine; Deuteroporphyrins; Enzyme Inhibitors; Escherichia coli; Fever; Heme Oxygenase (Decyclizing); Injections, Intraventricular; Iron; Lipopolysaccharides; Male; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar | 2001 |
Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.
Topics: Androstadienes; Animals; ATP-Binding Cassette Transporters; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Enzyme Activation; Female; Glyburide; Guanylate Cyclase; Hemodynamics; Hydroxybenzoates; KATP Channels; Male; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Potassium Channels; Potassium Channels, Inwardly Rectifying; Procollagen-Proline Dioxygenase; Proto-Oncogene Proteins c-akt; Quinoxalines; Rabbits; Reactive Oxygen Species; Wortmannin | 2006 |
Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; B-Lymphocytes; Chelating Agents; Deferoxamine; Indoles; Isotope Labeling; Lymph Nodes; Mice; Mice, Inbred DBA; Mice, Nude; Positron-Emission Tomography; Quinoxalines; Radiography; Radioimmunodetection; Radioisotopes; Spectrometry, Gamma; Spleen; Tissue Distribution; Zirconium | 2011 |
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Dioxolanes; Diterpenes; Drug Synergism; Fibroblasts; Humans; Iron; Mice; Pancreatic Neoplasms; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Spiro Compounds; Sulfasalazine | 2018 |
Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells.
Topics: Animals; Cell Death; Cell Line; Cyclohexylamines; Deferoxamine; Endothelial Cells; Ferroptosis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Phenylenediamines; Quinoxalines; Rats; Rats, Sprague-Dawley; Siderophores; Smoke; Spiro Compounds; Tissue Inhibitor of Metalloproteinase-1 | 2020 |
Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Deferoxamine; Dopaminergic Neurons; Ferric Compounds; Ferroptosis; Humans; Iron Chelating Agents; Iron Overload; Nerve Growth Factor; Neuroprotective Agents; Parkinson Disease, Secondary; Quaternary Ammonium Compounds; Quinoxalines; Rats; Reactive Oxygen Species; Spiro Compounds | 2021 |